Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
Get 40% Off
/Free Sign Up
 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Breaking News

Tesla stock tests 1-year lows as market cap drops below $500 billion

Atara Biotherapeutics Inc (ATRA)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Atara Biotherapeutics Inc's earnings

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
0.70 +0.02    +2.51%
10:07:11 - Real-time Cboe. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 132,039
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 0.66 - 0.72
Atara Biotherapeutics Inc 0.70 +0.02 +2.51%

ATRA Ratios

 
Assess the performance of Atara Biotherapeutics Inc (ATRA). This table contains core financial ratios such as Price-to-Earnings (P/E ratio), Return-On-Investment (ROI), Earnings per share (EPS), Dividend yield and others based on Atara Biotherapeutics Inc's latest financial reports. Compare the performance metrics of Atara Biotherapeutics Inc (ATRA) against the industry averages.
InvestingPro Advanced Ratios
Name Company Industry
   
P/E Ratio TTM -0.33 0.72
Price to Sales TTM 10.53 716.27
Price to Cash Flow MRQ -0.47 2.4
Price to Free Cash Flow TTM -0.46 -13.21
Price to Book MRQ -0.91 4.31
Price to Tangible Book MRQ -0.85 1.69
   
Profitability: TTM vs 5 Year Average Margins
 TTM (%)
 5 Year Avg. (%)
Gross margin TTM -2,560.12% -4,938.09
Gross Margin 5YA -1,145.8% -983.54
Operating margin TTM -3,140.98% -9,610
Operating margin 5YA -2,749.27% -2,917.21
Pretax margin TTM -3,220.7% -9,099.6
Pretax margin 5YA -2,743.44% -1,740.8
Net Profit margin TTM -3,220.88% -9,093.98
Net Profit margin 5YA -2,743.66% -4,772.71
   
Revenue/Share TTM 0.08 38.23
Basic EPS ANN -2.61 7.33
Diluted EPS ANN -2.61 6.96
Book Value/Share MRQ -0.97 63.04
Tangible Book Value/Share MRQ -0.93 47.77
Cash/Share MRQ 0.25 17.5
Cash Flow/Share TTM -1.89 9.15
   
Management Effectiveness: TTM vs 5 Year Average Margins
 TTM (%)
 5 Year Avg. (%)
Return on Equity TTM -436.08% -39.63
Return on Equity 5YA -130.5% -66.96
Return on Assets TTM -101.91% -13.87
Return on Assets 5YA -75.38% -11.93
Return on Investment TTM 0% -8.99
Return on Investment 5YA -59.49% -8.37
   
EPS(MRQ) vs Qtr. 1 Yr. Ago MRQ 16.02% -20.73
EPS(TTM) vs TTM 1 Yr. Ago TTM -16.47% -71.86
5 Year EPS Growth 5YA 0% 6.03
Sales (MRQ) vs Qtr. 1 Yr. Ago MRQ 1,345.7% 476.19
Sales (TTM) vs TTM 1 Yr. Ago TTM -86.51% 52.24
5 Year Sales Growth 5YA 0% 31.23
5 Year Capital Spending Growth 5YA -49.14% 20.56
   
Quick Ratio MRQ 0.6 6
Current Ratio MRQ 0.72 6.34
LT Debt to Equity MRQ 0% 39.81
Total Debt to Equity MRQ -60.96% 1.98
Efficiency    
Asset Turnover TTM 0.03 0.32
Inventory Turnover TTM 40.39 5.96
Revenue/Employee TTM 38.10K 608.57K
Net Income/Employee TTM -1.23M -401.07K
Receivable Turnover TTM 0.37 6.7
   
Dividend Yield ANN - 0.03
Dividend Yield 5 Year Avg. 5YA - 0.03
Dividend Growth Rate ANN 0% 0.8
Payout Ratio TTM - 1.83
TTM = Trailing Twelve Months  5YA = 5-Year Average  MRQ = Most Recent Quarter
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced valuation and financial ratios for in-depth analysis of company financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

ATRA Comments

Write your thoughts about Atara Biotherapeutics Inc
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Feb 03, 2024 4:01AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
The reason why people don't make it in crypto is because they haven't made a good decision towards their investments, this man has been the only one that has helped me out in some of my trade which has really helped me alot I pray God bless him and your family write him in wAsPP +31612574318) 01010101010101010101010101010101010616431213131645456464212453464613515454546454646454876424512131345546454546464646464613131242454849464645653131213131312121554545545421545454215454545454545454546434343121313121213457846
Reply
1 0
Report
Albi Ai
Albi Ai Mar 11, 2023 4:16AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Atara Biotherapeutics Inc - Currently Maintains Account At Svb Holding Cash Deposits Of About $2 Million
Reply
1 0
Report
Albi Ai
Albi Ai Mar 03, 2023 12:20PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
soon $2.83
Reply
0 1
Report
Albi Ai
Albi Ai Feb 08, 2023 11:18AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
today announced a collaboration with Pierre Fabre! stock going down...
Reply
0 0
Report
Albi Ai
Albi Ai Feb 08, 2023 11:18AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
why this stock always has a hard selloff on good news?
Reply
0 0
Report
simon Leblanc
simon Leblanc Feb 08, 2023 11:18AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
this stock is a good stock, the good run will come.
Reply
0 0
Report
Albi Ai
Albi Ai Feb 08, 2023 11:18AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
. its price is $ 1
Reply
0 0
Report
Albi Ai
Albi Ai Jan 19, 2023 9:51AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Does this stock go up, or does it always go down?
Reply
0 0
Report
Albi Ai
Albi Ai Oct 14, 2022 11:00AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Atara Biotherapeutics' Ebvallo Receives Approval Recommendation from CHMP👏👏👏🎉🥳🥳🥳🥳🥳🥳🥳
Reply
0 0
Report
Albi Ai
Albi Ai Sep 14, 2022 2:28PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
🚀
Reply
0 0
Report
Albi Ai
Albi Ai Aug 27, 2022 4:43AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
only short!
Reply
0 0
Report
Albi Ai
Albi Ai Aug 23, 2022 5:42AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
3,40-3,00 ..
Reply
0 1
Report
Albi Ai
Albi Ai Aug 17, 2022 3:46AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
4.75...4.40...after 🚀
Reply
0 0
Report
Albi Ai
Albi Ai Aug 17, 2022 3:46AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
only short!!
Reply
0 0
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email